Clinical trial · Interventional
Pancreatico Enteric Anastomosis Post Pancreaticoduodenectomy
Comparison Between Blumgart Anastomosis and Cattell Warren Anastomosis in Reduction of Post-Operative Complications After Pancreaticoduodenectomy Procedure
NCT05163977CI-TRIAL-00055591PEAPPunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to make a step for evaluation and presentation of a safe technique for pancreatico-jejunostomy that help in minimizing post-operative morbidity and mortality in pancreatic cancer patient by comparing Blumgart anastomosis with Cattell warren technique of anastomosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Pancreas | Malignant Pancreatic Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blumgart Anastomosis | Procedure | — | UNRESOLVED |
| Cattell Warren Anastomosis | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Cattell Warren Anastomosis
- interventionNames
- Procedure: Cattell Warren Anastomosis
- type
- EXPERIMENTAL
- label
- Blumgart Anastomosis
- interventionNames
- Procedure: Blumgart Anastomosis
Primary outcomes (1)
- measure
- Post-Operative Pancreatic Fistula
- timeFrame
- Up to 10 days after the operation
- description
- We used the International Study Group of Pancreatic Fistula (ISGPF) definition which is any measurable pancreatic fluid output after postoperative day 3 (containing more than three times the normal serum amylase level; more than 300 IU/L) with clinical signs of an infection and/or necessitating a change in clinical management.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Known Pancreatic head cancer diagnosed radiologically. * Operable and borderline pancreatic cancer. * Patients who will undergo upfront surgery and those who received neoadjuvant chemotherapy are included. Exclusion Criteria: * Metastatic patients. * Locally advanced cases. * Patients with comorbidities who are unfit for major surgical procedures. * Patients with very small pancreatic duct where the pancreatic duct can't be identified.
References
Publications (0)
Data not yet available
No reference posted for this study.